Symbol="REVB"
AssetType="Common Stock"
Name="Revelation Biosciences Inc"
Description="Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York."
CIK="1810560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="REAL ESTATE & CONSTRUCTION"
Industry="BLANK CHECKS"
Address="5 WEST 21ST STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4941300"
EBITDA="-5873009"
PERatio="0.0127"
PEGRatio="None"
BookValue="2.118"
DividendPerShare="0"
DividendYield="0"
EPS="64.08"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.282"
ReturnOnEquityTTM="0.392"
RevenueTTM="0"
GrossProfitTTM="90905000"
DilutedEPSTTM="64.08"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="11.45"
TrailingPE="0.0127"
ForwardPE="7.79"
PriceToSalesRatioTTM="2.882"
PriceToBookRatio="0.891"
EVToRevenue="-"
EVToEBITDA="-"
Beta="0.308"
num_52WeekHigh="63.7"
num_52WeekLow="0.722"
num_50DayMovingAverage="1.029"
num_200DayMovingAverage="4.541"
SharesOutstanding="6048900"
DividendDate="None"
ExDividendDate="None"
symbol="REVB"
open="0.84"
high="0.84"
low="0.72"
price="0.82"
volume="276126.00"
latest_trading_day="2023-07-17"
previous_close="0.84"
change="-0.02"
change_percent="-2.4364%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="537640"
Change_recent_avg="-0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.85"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="1152"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0185.jpeg"
image_negative_thumbnail_id_2="121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="667"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_positive_thumbnail_id_2="950"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0112.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
